Literature DB >> 16455372

Proinflammatory effects of Staphylococcus aureus exotoxin B on nasal epithelial cells.

Michael Damm1, Gero Quante, Jakob Rosenbohm, Roland Rieckmann.   

Abstract

OBJECTIVE: The aim of this study was to evaluate the effects of Staphylococcus aureus exotoxin B (SE-B) on proinflammatory cytokine/chemokine releases in primary nasal epithelial cell cultures (NECC) of subjects with and without chronic rhinosinusitis (CRS). STUDY DESIGN AND
SETTING: NECC (CRS: n = 14; CONTROLS: n = 11) were stimulated with SE-B. Protein concentrations of interleukin-(IL)-1beta, IL-6, and IL-8 levels were measured in NECC supernatants by ELISA before (T0) and after 24 hr stimulation with SE-B (T1).
RESULTS: T0: supernatants of the NECC of CRS patients contained significant lower levels of IL-8 (2.1 ng/ml) compared to CONTROLS (IL-8: 6.2 ng/ml; P < 0.01). T1: SE-B induced a significant increase of IL-6 in NECC (P < 0.001). IL-1beta was not detectable.
CONCLUSIONS: This is the first study evaluating the effects of exotoxins on NECC. SE-B showed proinflammatory effects on NECC. SIGNIFICANCE: Our data suggest that resident NECC are involved in immunological responses to Staphylococcus aureus toxins, supplementing the so-called "superantigen hypothesis" in CRS.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16455372     DOI: 10.1016/j.otohns.2005.11.016

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  9 in total

1.  A disintegrin and metalloproteinase 17 (ADAM17) and epidermal growth factor receptor (EGFR) signaling drive the epithelial response to Staphylococcus aureus toxic shock syndrome toxin-1 (TSST-1).

Authors:  Laura M Breshears; Patrick M Schlievert; Marnie L Peterson
Journal:  J Biol Chem       Date:  2012-07-25       Impact factor: 5.157

2.  Pro-inflammatory effects of ochratoxin A on nasal epithelial cells.

Authors:  Birgit Cremer; Alexandra Soja; Jan-Alex Sauer; Michael Damm
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-11-02       Impact factor: 2.503

Review 3.  Gram-positive bacterial superantigen outside-in signaling causes toxic shock syndrome.

Authors:  Amanda J Brosnahan; Patrick M Schlievert
Journal:  FEBS J       Date:  2011-05-19       Impact factor: 5.542

Review 4.  Perspectives on the etiology of chronic rhinosinusitis: an immune barrier hypothesis.

Authors:  Robert C Kern; David B Conley; William Walsh; Rakesh Chandra; Atsushi Kato; Anju Tripathi-Peters; Leslie C Grammer; Robert P Schleimer
Journal:  Am J Rhinol       Date:  2008-09-10

5.  Staphylococcus aureus enterotoxins induce IL-8 secretion by human nasal epithelial cells.

Authors:  Garrett J O'Brien; Gareth Riddell; J Stuart Elborn; Madeleine Ennis; Grzegorz Skibinski
Journal:  Respir Res       Date:  2006-09-04

6.  Reduced Innate Immune Response to a Staphylococcus aureus Small Colony Variant Compared to Its Wild-Type Parent Strain.

Authors:  Judy J J Ou; Amanda J Drilling; Clare Cooksley; Ahmed Bassiouni; Stephen P Kidd; Alkis J Psaltis; Peter J Wormald; Sarah Vreugde
Journal:  Front Cell Infect Microbiol       Date:  2016-12-26       Impact factor: 5.293

Review 7.  Staphylococcus aureus colonization and non-influenza respiratory viruses: Interactions and synergism mechanisms.

Authors:  M Fedy Morgene; Elisabeth Botelho-Nevers; Florence Grattard; Sylvie Pillet; Philippe Berthelot; Bruno Pozzetto; Paul O Verhoeven
Journal:  Virulence       Date:  2018       Impact factor: 5.882

8.  Elevated microRNA-21 Is a Brake of Inflammation Involved in the Development of Nasal Polyps.

Authors:  Ruowu Liu; Jintao Du; Jiao Zhou; Bing Zhong; Luo Ba; Jie Zhang; Yafeng Liu; Shixi Liu
Journal:  Front Immunol       Date:  2021-04-15       Impact factor: 7.561

9.  Aberrant cytokine pattern of the nasal mucosa in granulomatosis with polyangiitis.

Authors:  Janet Wohlers; Katrin Breucker; Rainer Podschun; Jürgen Hedderich; Peter Lamprecht; Petra Ambrosch; Martin Laudien
Journal:  Arthritis Res Ther       Date:  2012-10-17       Impact factor: 5.156

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.